Literature DB >> 31190670

Health Technology Assessment in Thailand: Institutionalization and Contribution to Healthcare Decision Making: Review of Literature.

Pattara Leelahavarong1, Suradech Doungthipsirikul1, Suthasinee Kumluang1, Akanittha Poonchai1, Nitichen Kittiratchakool1, Danai Chinnacom1, Netnapis Suchonwanich1, Sripen Tantivess1.   

Abstract

OBJECTIVES: To explore health technology assessment (HTA) in Thailand focusing on its institutionalization, key elements for HTA introduction, and HTA contribution to policy.
METHODS: A review of literature covered a wide range of topics, including the institutionalization of HTA, elements of HTA introduction, and the role of HTA in policy decision making in Thai context. Additional information from the authors' involvement in the policy decision-making process in Thailand was also considered.
RESULTS: HTA institutionalization comprises processes of introducing HTA, including evidence generation and use in policymaking, building capacity of HTA practitioners, organizations, system infrastructure, and collaborations. In Thailand, HTA has been formally integrated into coverage decisions, including in the development of the National List of Essential Medicines and the Universal Health Coverage Scheme benefits package. Contributing factors included political will and leadership, capacity building on HTA-related disciplines, adequate resources, technical expertise, and data. Conversely, challenges faced included the absence of a governing body and strategic plan for HTA systems development, a lack of formal mechanisms for mobilizing financial support, an inadequate number of HTA researchers in nonprofit institutes, and the rise in advanced biotechnologies.
CONCLUSIONS: HTA plays an important role in evidence-based healthcare decision making. However, key elements of HTA institutionalization need to be strengthened, especially governance structure and policy for HTA systems development, building and retaining capacity of HTA practitioners to meet demand, addressing the challenges of complex and highly innovative health interventions. Lessons learned from the Thai experience may be used as guidance for HTA institutionalization in other developing countries.

Keywords:  Decision making; Health technology assessment; Institutionalization; Thailand

Mesh:

Year:  2019        PMID: 31190670     DOI: 10.1017/S0266462319000321

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  9 in total

1.  Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.

Authors:  Wija Oortwijn; Don Husereau; Julia Abelson; Edwine Barasa; Diana Dana Bayani; Vania Canuto Santos; Anthony Culyer; Karen Facey; David Grainger; Katharina Kieslich; Daniel Ollendorf; Andrés Pichon-Riviere; Lars Sandman; Valentina Strammiello; Yot Teerawattananon
Journal:  Int J Technol Assess Health Care       Date:  2022-06-03       Impact factor: 2.406

2.  Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.

Authors:  Wija Oortwijn; Don Husereau; Julia Abelson; Edwine Barasa; Diana Dana Bayani; Vania Canuto Santos; Anthony Culyer; Karen Facey; David Grainger; Katharina Kieslich; Daniel Ollendorf; Andrés Pichon-Riviere; Lars Sandman; Valentina Strammiello; Yot Teerawattananon
Journal:  Value Health       Date:  2022-06       Impact factor: 5.101

3.  Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand.

Authors:  Rungroj Krittayaphong; Unchalee Permsuwan
Journal:  Clin Drug Investig       Date:  2021-09-17       Impact factor: 3.580

Review 4.  National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison.

Authors:  Deepshikha Sharma; Arun Kumar Aggarwal; Laura E Downey; Shankar Prinja
Journal:  Pharmacoecon Open       Date:  2021-01-10

5.  A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region.

Authors:  Manushi Sharma; Yot Teerawattananon; Saudamini Vishwanath Dabak; Wanrudee Isaranuwatchai; Fiona Pearce; Songyot Pilasant; Junainah Sabirin; Mayfong Mayxay; Melissa Guerrero; Nguyen Khanh Phuong; Sudigdo Sastroasmoro; Thant Sin Htoo
Journal:  Health Res Policy Syst       Date:  2021-02-11

6.  Application of Discrete Choice Experiment in Health Care: A Bibliometric Analysis.

Authors:  Yue Wang; Zhangyi Wang; Zhao Wang; Xuechun Li; Xiaoli Pang; Shuling Wang
Journal:  Front Public Health       Date:  2021-06-04

7.  Cost-utility and budget impact analysis of tocilizumab for the treatment of refractory systemic juvenile idiopathic arthritis in Thailand.

Authors:  Nitichen Kittiratchakool; Disorn Kulpokin; Chonticha Chanjam; Soamarat Vilaiyuk; Sirirat Charuvanij; Gun Phongsamart; Parichat Khaosut; Manasita Tanya; Ratanavadee Nanagara; Sira Nantapaisarn; Pattara Leelahavarong
Journal:  BMJ Open       Date:  2020-09-15       Impact factor: 2.692

8.  Institutionalizing Evidence-Informed Priority Setting for Universal Health Coverage: Lessons From Indonesia.

Authors:  Manushi Sharma; Yot Teerawattananon; Alia Luz; Ryan Li; Waranya Rattanavipapong; Saudamini Dabak
Journal:  Inquiry       Date:  2020 Jan-Dec       Impact factor: 1.730

9.  Contextualization of cost-effectiveness evidence from literature for 382 health interventions for the Ethiopian essential health services package revision.

Authors:  Alemayehu Hailu; Getachew Teshome Eregata; Amanuel Yigezu; Melanie Y Bertram; Kjell Arne Johansson; Ole F Norheim
Journal:  Cost Eff Resour Alloc       Date:  2021-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.